PARP1 and lung adenocarcinoma: Parallel to the current results, previous studies reported a high expression of PARP1 in several malignancies including all subtypes of lung cancer especially squamous cell and lung adenocarcinomas enhancing lung cancer survival and metastasis [45, 46].